Clinical Trials

Showing trials with last updates posted in 2022.

NCT02706405 | TERMINATED | PHASE1
30 participants

JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-24
Start Date:
2016-11-15
Completion:
2021-05-28
Conditions
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
NCT02349217 | COMPLETED | NA
24 participants

Mindfulness Based Couples Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-24
Start Date:
2015-01-23
Completion:
2022-08-01
Conditions
  • Breast Cancer
Interventions
  • BEHAVIORAL
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page